Form 4: Astrana Health CFO Chandan Basho Reports Acquisition of 15,692 Restricted Stock Units

Chandan Basho, CFO and COO of Astrana Health, Inc., reports the acquisition of 15,692 restricted stock units on April 2, 2024.

Summary

• On April 2, 2024, Chandan Basho, the CFO and COO of Astrana Health, Inc., acquired 15,692 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of Astrana Health's common stock.
• The shares will vest in eight equal semi-annual installments beginning on October 2, 2024, provided Basho remains employed with the Issuer.
• Following the reported transaction, Basho beneficially owns 172,783 shares of common stock, including unvested restricted stock.
• The unvested restricted stock includes shares vesting in annual installments through 2027 and shares vesting upon achievement of certain pre-established performance goals.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The grant of restricted stock units is generally a positive sign, but it's a routine event and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The grant of restricted stock units to a key executive like the CFO and COO can be seen as a positive sign, aligning their interests with the long-term success of the company.
• The vesting schedule, tied to continued employment and potentially performance goals, incentivizes the executive to remain with the company and contribute to its growth.

Risks

• The value of the restricted stock units is dependent on the future performance of Astrana Health's stock, which is subject to market risks.
• If Chandan Basho leaves the company before the restricted stock units fully vest, they may be forfeited.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that the CFO has been granted additional equity, which is a common practice in the healthcare industry to incentivize executives.

Comparison to Industry Standards

• Equity compensation for CFOs in the healthcare industry typically includes a mix of salary, bonus, stock options, and restricted stock units.
• The amount of equity granted varies depending on the size and performance of the company, as well as the individual's role and responsibilities.
• Benchmarking against companies like UnitedHealth Group, CVS Health, or Humana would provide a better understanding of the relative size and structure of this equity grant.

Stakeholder Impact

• The grant of restricted stock units aligns the CFO's interests with those of shareholders, as the value of the units is tied to the company's stock performance.
• Employees may view this as a positive sign, indicating the company's commitment to rewarding its executives.

Key Dates